1 false false false false false false false false false false true false false false false false false No description of principal activity 2025-05-01 Sage Accounts Production Advanced 2025 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 09558217 2025-05-01 2026-04-30 09558217 2026-04-30 09558217 2025-04-30 09558217 2024-05-01 2025-04-30 09558217 2025-04-30 09558217 2024-04-30 09558217 bus:Director1 2025-05-01 2026-04-30 09558217 core:WithinOneYear 2026-04-30 09558217 core:WithinOneYear 2025-04-30 09558217 bus:Director1 2025-04-30 09558217 bus:Director1 2024-04-30 09558217 bus:Micro-entities 2025-05-01 2026-04-30 09558217 bus:AuditExemptWithAccountantsReport 2025-05-01 2026-04-30 09558217 bus:SmallCompaniesRegimeForAccounts 2025-05-01 2026-04-30 09558217 bus:PrivateLimitedCompanyLtd 2025-05-01 2026-04-30 09558217 bus:FullAccounts 2025-05-01 2026-04-30
COMPANY REGISTRATION NUMBER: 09558217

FSFMED LIMITED

Filleted Unaudited Financial Statements

30 April 2026

FSFMED LIMITED

Statement of Financial Position

30 April 2026

| 2026 | 2025
| £ | £
Creditors: amounts falling due within one year | 2,724 | 2,447
| ------- | -------
Net current liabilities | 2,724 | 2,447
| ------- | -------
Total assets less current liabilities | ( 2,724) | ( 2,447)
| ------- | -------

Capital and reserves | ( 2,724) | ( 2,447)
| ------- | -------

Notes to the financial statements
1. Employee numbers
The average number of persons employed by the company during the year amounted to 1 (2025: 1 ).
2. Director's advances, credits and guarantees
During the year the director entered into the following advances and credits with the company:

| Balance brought forward and outstanding
| 2026 | 2025
| £ | £
Dr S Ugharadar | ( 2,724) | ( 2,439)
| ------- | -------

For the year ending 30 April 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 1 June 2026 , and are signed on behalf of the board by:

Dr S Ugharadar |
Director |

Company registration number: 09558217
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 11 Ripplewaters, St. Marys Island, Chatham, Kent, ME4 3BL.